These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 3493051

  • 1. The clinical significance of the anticentromere antibody.
    Miller MH, Littlejohn GO, Davidson A, Jones B, Topliss DJ.
    Br J Rheumatol; 1987 Feb; 26(1):17-21. PubMed ID: 3493051
    [Abstract] [Full Text] [Related]

  • 2. A long-term longitudinal study of anticentromere antibodies.
    Tramposch HD, Smith CD, Senecal JL, Rothfield N.
    Arthritis Rheum; 1984 Feb; 27(2):121-4. PubMed ID: 6607733
    [Abstract] [Full Text] [Related]

  • 3. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
    Chen ZY, Fedrick JA, Pandey JP, Silver R, Maricq HR, Fudenberg HH, Dobson RL, Ainsworth SK.
    Arch Dermatol; 1985 Mar; 121(3):339-44. PubMed ID: 3883903
    [Abstract] [Full Text] [Related]

  • 4. The CREST syndrome: a distinct serologic entity with anticentromere antibodies.
    Fritzler MJ, Kinsella TD.
    Am J Med; 1980 Oct; 69(4):520-6. PubMed ID: 6968511
    [Abstract] [Full Text] [Related]

  • 5. The anticentromere antibody: disease specificity and clinical significance.
    Powell FC, Winkelmann RK, Venencie-Lemarchand F, Spurbeck JL, Schroeter AL.
    Mayo Clin Proc; 1984 Oct; 59(10):700-6. PubMed ID: 6384675
    [Abstract] [Full Text] [Related]

  • 6. Anticentromere and anticentriole antibodies in the scleroderma spectrum.
    Tuffanelli DL, McKeon F, Kleinsmith DM, Burnham TK, Kirschner M.
    Arch Dermatol; 1983 Jul; 119(7):560-6. PubMed ID: 6859899
    [Abstract] [Full Text] [Related]

  • 7. Anticentromere antibody. Clinical Correlations and association with favorable prognosis in patients with scleroderma variants.
    McCarty GA, Rice JR, Bembe ML, Barada FA.
    Arthritis Rheum; 1983 Jan; 26(1):1-7. PubMed ID: 6337593
    [Abstract] [Full Text] [Related]

  • 8. [Anti-centromere antibody, biological marker of the CREST syndrome as distinct from scleroderma].
    Rouquette-Gally AM, Stern MH, Prost AC, Abuaf N, Homberg JC, Combrisson A.
    Presse Med; 1983 Jan; 14(28):1497-500. PubMed ID: 2931679
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of methods for detection of anticentromere antibodies and other antinuclear antibodies.
    Beutner EH, Krasny SA, Chorzelski TP, Rodnan G, Jablonska S, Kumar V.
    J Am Acad Dermatol; 1985 Feb; 12(2 Pt 1):289-95. PubMed ID: 3882784
    [Abstract] [Full Text] [Related]

  • 10. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S, Asanuma H, Nishiyama S, Yoshinaga Y.
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [Abstract] [Full Text] [Related]

  • 11. Anticentromere antibody: an immunological marker of a subset of systemic sclerosis.
    Chorzelski TP, Jablonska S, Beutner EH, Blaszczyk M, Jarzabek-Chorzelska M, Kencka D, Krasny S, Kumar V, Tchórzewska A.
    Br J Dermatol; 1985 Oct; 113(4):381-9. PubMed ID: 3877519
    [Abstract] [Full Text] [Related]

  • 12. Anticentromere antibody in patients without CREST and scleroderma: association with active digital vasculitis, rheumatic and connective tissue disease.
    Goldman JA.
    Ann Rheum Dis; 1989 Sep; 48(9):771-5. PubMed ID: 2802800
    [Abstract] [Full Text] [Related]

  • 13. [Anticentromere antibody, CREST and cancer].
    Boyeldieu D, Rouquette-Gally AM, Laugier A, Abuaf N.
    Presse Med; 1987 Nov 14; 16(38):1924-5. PubMed ID: 2962150
    [No Abstract] [Full Text] [Related]

  • 14. Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis.
    Steen VD, Ziegler GL, Rodnan GP, Medsger TA.
    Arthritis Rheum; 1984 Feb 14; 27(2):125-31. PubMed ID: 6607734
    [Abstract] [Full Text] [Related]

  • 15. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
    Uchida K, Kondo H, Kashiwazaki S.
    Ryumachi; 1984 Aug 14; 24(4):241-9. PubMed ID: 6334895
    [No Abstract] [Full Text] [Related]

  • 16. Proteins responsible for anticentromere activity found in the sera of patients with CREST-associated Raynaud's phenomenon.
    Kremer L, Alvaro-Gracia JM, Ossorio C, Avila J.
    Clin Exp Immunol; 1988 Jun 14; 72(3):465-9. PubMed ID: 3048807
    [Abstract] [Full Text] [Related]

  • 17. Calcinosis and the anticentromere antibody: its clinical, radiological and immunogenetic aspects.
    Nishikai M, Itoh K, Sato A.
    Br J Rheumatol; 1992 Jan 14; 31(1):9-12. PubMed ID: 1730111
    [Abstract] [Full Text] [Related]

  • 18. Anti-centromere antibodies (ACA).
    Kallenberg CG.
    Clin Rheumatol; 1990 Mar 14; 9(1 Suppl 1):136-9. PubMed ID: 2203592
    [No Abstract] [Full Text] [Related]

  • 19. Anticentromere antibody positive CREST syndrome associated with polyarthritis, renal impairment and mixed cryoglobulinaemia.
    Shetty HG, O'Sullivan MM, Amos N, Williams BD.
    Clin Rheumatol; 1989 Sep 14; 8(3):381-5. PubMed ID: 2805613
    [Abstract] [Full Text] [Related]

  • 20. Anti-centromere antibody and CREST syndrome in patients with primary biliary cirrhosis.
    Shoji I, Takagi T, Kasukawa R.
    Intern Med; 1992 Dec 14; 31(12):1348-55. PubMed ID: 1284406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.